Search
for
Sort by
Research 901–930 of 1000+
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- Research Progress of Skin Barrier and Acne
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- The role of janus kinases in the treatment of autoimmune skin diseases
- Treatments for alopecia areata: a network meta-analysis
- Pharmacological Treatment of Alopecia
- Alopecia Areata and Alopecia Areata Incognita
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- 878 Individual variation in balance between platelet-secreted growth factors causing contradictory effects on hair follicle could potentially impact response to PRP therapy in patients with scalp hair loss
- Diuretics
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- A computationally inferred regulatory heart aging model including post-transcriptional regulations
- Transplantation of melanocyte stem cells in vitiliginous skin
- Melanocytes and Vitiligo (and Hair Graying)
- ALOPECIA AREATA-A CLINICAL ANALYSIS
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- The Skin and Subcutaneous Tissues
- Psikonöroimmünoloji ve Multifaktöryel Psikodermatolojik Hastalıklar
- Cutaneous drug reactions
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Gene Therapy: Recent Advances and Applications in Dermatology
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Skin aging: mechanisms, evaluation, and rejuvenation
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- SPT6 maintains epidermal homeostasis by inhibiting an NF-κB-positive feedback loop to prevent excessive inflammation